• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Food and Drug Administration
Pharma

Regulatory tracker: Tremfya, Venclyxto secure label expansions

Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Angus Liu , Eric Sagonowsky , Fraiser Kansteiner , Kevin Dunleavy , Zoey Becker May 29, 2026 10:12am
china chinese Asia

More biotech hawkishness, Pfizer’s $10B deal—Fierce Pharma Asia

May 29, 2026 8:30am
Eliminating KRAS Why targeted protein degraders could redefinewhatspossible in cancer

Eliminating KRAS: How degraders could redefine cancer care

Brought to you by ASTELLAS
Pills medicine in Dollar sign shape on blue background

Brand-name drug prices climb with age in US, fall abroad: report

May 29, 2026 8:10am
Real-World Evidence in the AI Era What You Can Unlock Depends on What You Build On

RWE in the AI Era: What You Unlock Depends on What You Build On

Brought to you by Flatiron Health
Two fencers spar in a stadium

Dizal takes on J&J with first-line win in EGFR lung cancer type

May 29, 2026 8:00am
More News

Pharma urged to adapt support to changing patient populations

May 29, 2026 6:45am

Philips adds a spoonful of Disney sugar to ease MRI anxieties

May 29, 2026 5:25am

AZ gains on Merck with 2nd bladder cancer nod for Imfinzi

May 28, 2026 4:39pm

Global pharma leaders convene in Japan

May 28, 2026 11:37am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings